These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Counterpoint: Overdiagnosis in breast cancer screening. Smith RA J Am Coll Radiol; 2014 Jul; 11(7):648-52. PubMed ID: 24794765 [No Abstract] [Full Text] [Related]
6. Lead-time models produce far too low estimates of overdiagnosis with mammographic screening. Gøtzsche PC; Jørgensen KJ; Zahl PH J Am Coll Radiol; 2014 Nov; 11(11):1098. PubMed ID: 25301416 [No Abstract] [Full Text] [Related]
7. Organised mammographic screening--more benefits than harms. Hofvind S Tidsskr Nor Laegeforen; 2013 Mar; 133(6):619-20. PubMed ID: 23552154 [No Abstract] [Full Text] [Related]
8. Point: Mammography, breast cancer, and overdiagnosis: the truth versus the whole truth versus nothing but the truth. Berlin L J Am Coll Radiol; 2014 Jul; 11(7):642-7. PubMed ID: 24794764 [No Abstract] [Full Text] [Related]
9. Re: "counterpoint: overdiagnosis in breast cancer screening". Miller A J Am Coll Radiol; 2014 Sep; 11(9):923. PubMed ID: 24928060 [No Abstract] [Full Text] [Related]
10. Should women 40 to 49 years of age be offered mammographic screening? Trop I; Deck W Can Fam Physician; 2006 Sep; 52(9):1050-2. PubMed ID: 17279208 [No Abstract] [Full Text] [Related]
11. [Mortality in breast cancer is decreasing--but not because of screening. Time to abolish the mammography screening]. Jørgensen KJ; Gøtzsche PC Lakartidningen; 2012 Mar 28-Apr 3; 109(13):690-2. PubMed ID: 22530466 [No Abstract] [Full Text] [Related]
12. Breast cancer screening. Stat Bull Metrop Insur Co; 1991; 72(1):12-6. PubMed ID: 2011815 [TBL] [Abstract][Full Text] [Related]
13. [The National Board of Health and Welfare on mammographic screening: mortality analysis requires completely different methods]. Rehnqvist N; Rosén M; Karlberg I Lakartidningen; 1999 Mar; 96(9):1050-1. PubMed ID: 10093453 [No Abstract] [Full Text] [Related]
14. The 2003 Australian Breast Health Survey: survey design and preliminary results. Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528 [TBL] [Abstract][Full Text] [Related]
15. Mass mammographic screening--the other side of the argument. Liddell MJ Aust Fam Physician; 1993 Jul; 22(7):1168-75. PubMed ID: 8123107 [TBL] [Abstract][Full Text] [Related]
16. Update of the Swedish two-county program of mammographic screening for breast cancer. Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926 [TBL] [Abstract][Full Text] [Related]
17. Are there downsides to mammography screening? Baines CJ Breast J; 2005; 11 Suppl 1():S7-10. PubMed ID: 15725116 [TBL] [Abstract][Full Text] [Related]
18. [Mammography screening: presentation of scientific evidence as a basis for communication with women]. Mühlhauser I; Höldke B Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):721-31. PubMed ID: 11127779 [TBL] [Abstract][Full Text] [Related]
19. Point/Counterpoint: recent data show that mammographic screening of asymptomatic women is effective and essential. Javitt MC; Hendrick RE; Keen JD; Jorgensen KJ; Orton CG Med Phys; 2012 Jul; 39(7):4047-50. PubMed ID: 22830737 [No Abstract] [Full Text] [Related]
20. Effect of service screening mammography on population mortality from breast carcinoma. Feig SA Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736 [No Abstract] [Full Text] [Related] [Next] [New Search]